Literature DB >> 35064201

Prevalence and assessment of self-disorders in the schizophrenia spectrum: a systematic review and meta-analysis.

Sam Burgin1, Renate Reniers2,3, Clara Humpston4.   

Abstract

Self-disorders have been proposed as the "clinical core" of the schizophrenia spectrum. This has been explored in recent studies using self-disorder assessment tools. However, there are few systematic discussions of their quality and utility. Therefore, a literature search was performed on Medline, Embase, PsychINFO, PubMed and the Web of Science. Studies using these assessment tools to explore self-disorders within schizophrenia spectrum disorders (SSDs) were included. A meta-analysis was performed on the outcomes of total self-disorder score and odds ratios of self-disorders, using Comprehensive Meta-Analysis software. Weighted pooled effect sizes in Hedge's g were calculated using a random-effects model. 15 studies were included, giving a sample of 810 participants on the schizophrenia spectrum. Self-disorders showed a greater aggregation within schizophrenia spectrum groups compared to non-schizophrenia spectrum groups, as measured with the Bonn Scale for the Assessment of Basic Symptoms (Hedge's g = 0.774, p < 0.01) and Examination of Anomalous Self-Experiences (Hedge's g = 1.604, p < 0.01). Also, self-disorders had a greater likelihood of occurring within SSDs (odds ratio = 5.435, p < 0.01). These findings help to validate self-disorders as a core clinical feature of the broad schizophrenia spectrum.
© 2022. The Author(s).

Entities:  

Mesh:

Year:  2022        PMID: 35064201      PMCID: PMC8782935          DOI: 10.1038/s41598-022-05232-9

Source DB:  PubMed          Journal:  Sci Rep        ISSN: 2045-2322            Impact factor:   4.996


  36 in total

1.  Anomalous subjective experience among first-admitted schizophrenia spectrum patients: empirical investigation.

Authors:  Josef Parnas; Peter Handest; Lennart Jansson; Ditte Saebye
Journal:  Psychopathology       Date:  2005-09-20       Impact factor: 1.944

Review 2.  Subjective symptoms of schizophrenia in research and the clinic: the basic symptom concept.

Authors:  Frauke Schultze-Lutter
Journal:  Schizophr Bull       Date:  2009-01       Impact factor: 9.306

Review 3.  Thinking, believing, and hallucinating self in schizophrenia.

Authors:  Clara S Humpston; Matthew R Broome
Journal:  Lancet Psychiatry       Date:  2020-02-24       Impact factor: 27.083

Review 4.  Neurobiological Models of Self-Disorders in Early Schizophrenia.

Authors:  A Mishara; I Bonoldi; P Allen; G Rutigliano; J Perez; P Fusar-Poli; P McGuire
Journal:  Schizophr Bull       Date:  2015-09-18       Impact factor: 9.306

5.  Is basic self-disturbance in ultra-high risk for psychosis ('prodromal') patients associated with borderline personality pathology?

Authors:  Barnaby Nelson; Andrew Thompson; Andrew M Chanen; Günther Paul Amminger; Alison R Yung
Journal:  Early Interv Psychiatry       Date:  2013-01-24       Impact factor: 2.732

Review 6.  Schizophrenia, consciousness, and the self.

Authors:  Louis A Sass; Josef Parnas
Journal:  Schizophr Bull       Date:  2003       Impact factor: 9.306

7.  Reliability of measuring anomalous experience: the Bonn Scale for the Assessment of Basic Symptoms.

Authors:  Anne Vollmer-Larsen; Peter Handest; Josef Parnas
Journal:  Psychopathology       Date:  2007-07-24       Impact factor: 1.944

Review 8.  A disappearing heritage: the clinical core of schizophrenia.

Authors:  Josef Parnas
Journal:  Schizophr Bull       Date:  2011-07-19       Impact factor: 9.306

9.  Thought Insertion as a Self-Disturbance: An Integration of Predictive Coding and Phenomenological Approaches.

Authors:  Philipp Sterzer; Aaron L Mishara; Martin Voss; Andreas Heinz
Journal:  Front Hum Neurosci       Date:  2016-10-12       Impact factor: 3.169

10.  Is Schizophrenia a Disorder of Consciousness? Experimental and Phenomenological Support for Anomalous Unconscious Processing.

Authors:  Anne Giersch; Aaron L Mishara
Journal:  Front Psychol       Date:  2017-09-28
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.